Wonder, Michael J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Evaluation of the residual effectiveness of Fludora™ fusion WP-SB, a combination of clothianidin and deltamethrin, for the control of pyrethroid-resistant malaria vectors on Bioko Island, Equatorial Guinea

Fuseini, Godwin, Phiri, Wonder P., von Fricken, Michael E., Smith, Jordan, Garcia, Guillermo A.

Journal:

Year:

2019

Language:

english

File:

PDF, 587 KB

english, 2019

2

Analysis of sponsor hearings on health technology assessment decision making

Flowers, Melinda, Lybrand, Sean, Wonder, Michael

Journal:

Australian Health Review

Year:

2019

File:

PDF, 162 KB

2019

3

Assessment of the Quality of the Clinical Evidence in Submissions to the Australian Pharmaceutical Benefits Advisory Committee: Fit for Purpose?

Wonder, Michael, Dunlop, Sheryl

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 522 KB

english, 2015

4

Australian Managed Entry Scheme: A New Manageable Process for the Reimbursement of New Medicines?

Michael Wonder, Martin E. Backhouse, Sean D. Sullivan

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 395 KB

english, 2012

5

OBITUARY

Wonder, Michael, Milne, Richard

Journal:

Year:

1939

Language:

english

File:

PDF, 627 KB

english, 1939

6

Association of HLA - DRB1 with Sarcoidosis Susceptibility and Progression in African Americans

Levin, Albert M., Adrianto, Indra, Datta, Indrani, Iannuzzi, Michael C., Trudeau, Sheri, Li, Jia, Drake, Wonder P., Montgomery, Courtney G., Rybicki, Benjamin A.

Journal:

American Journal of Respiratory Cell and Molecular Biology

Year:

2015

Language:

english

File:

PDF, 1.36 MB

english, 2015

7

Exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand

Taylor, Colman, Wonder, Michael

Journal:

Australian Health Review

Year:

2015

Language:

english

File:

PDF, 196 KB

english, 2015

8

Early Scientific Advice Obtained Simultaneously from Regulators and Payers: Findings from a Pilot Study in Australia

Wonder, Michael, Backhouse, Martin E., Hornby, Edward

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 998 KB

english, 2013

9

Rescuing Patients from the Rule of Efficiency

Sophia Kessabi,Richard de Abreu Lourenco,Michael Wonder

Journal:

PharmacoEconomics

Year:

2003

Language:

english

File:

PDF, 49 KB

english, 2003

10

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report—Part V

Jack M. Mycka, Renato Dellamano, Eugene Mick Kolassa, Michael Wonder, Sabyasachi Ghosh, Joel W. Hay, Jim Smeeding

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 58 KB

english, 2010

11

What impact does ‘conventional’ economic evaluation have on patient access to new orphan medicines? A comparative study of their reimbursement in Australia (2005–2012)

Wonder, Michael, Chin, Geoffrey

Journal:

Expert Review of Pharmacoeconomics & Outcomes Research

Year:

2015

Language:

english

File:

PDF, 958 KB

english, 2015

12

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Hardy, Timothy, Wonders, Kristy, Younes, Ramy, Aithal, Guruprasad P., Aller, Rocio, Allison, Michael, Bedossa, Pierre, Betsou, Fay, Boursier, Jerome, Brosnan, M. Julia, Burt, Alastair, Cobbold, Jeremy

Journal:

Contemporary Clinical Trials

Year:

2020

File:

PDF, 1.28 MB

2020

13

Patient Access to New Cancer Drugs in the United States and Australia

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 251 KB

english, 2012

14

Analysis of PBAC submissions and outcomes for medicines (2010â2018)

Lybrand, Sean, Wonder, Michael

Journal:

International Journal of Technology Assessment in Health Care

Year:

2020

File:

PDF, 328 KB

2020

15

Early Dialogue Between the Developers of New Technologies and Pricing and Reimbursement Agencies: A Pilot Study

Martin E. Backhouse, Michael Wonder, Edward Hornby, Anne Kilburg, Michael Drummond, Friedrich Karl Mayer

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 595 KB

english, 2011

16

Development of a predictive population survival model according to the cytogenetic response rate for patients with chronic myeloid leukemia in the chronic phase

Schrover, Rudolf J., Adena, Michael A., De Abreu Lourenco, Richard, Miles Prince, H., Seymour, John F., Wonder, Michael J.

Journal:

Leukemia and Lymphoma

Year:

2006

Language:

english

File:

PDF, 218 KB

english, 2006

17

Correspondence

Michael Wonder,José A. Sacristán,Elena Bolaños,Jesús M. Hernández…

Journal:

PharmacoEconomics

Year:

1997

Language:

english

File:

PDF, 5.61 MB

english, 1997

18

Tissue Plasminogen Activator Combined With Human Recombinant Deoxyribonuclease Is Effective Therapy for Empyema in a Rabbit Model

Zhu, Zhiwen, Hawthorne, Michael L., Guo, Yubiao, Drake, Wonder, Bilaceroglu, Semra, Misra, Heather L., Light, Richard W.

Journal:

Year:

2006

Language:

english

File:

PDF, 168 KB

english, 2006

19

Improving the performance of spray operators through monitoring and evaluation of insecticide concentrations of pirimiphos-methyl during indoor residual spraying for malaria control on Bioko Island

Fuseini, Godwin, Ismail, Hanafy M., von Fricken, Michael E., Weppelmann, Thomas A., Smith, Jordan, Ellis Logan, Rhiannon Agnes, Oladepo, Folasade, Walker, Kyle J., Phiri, Wonder P., Paine, Mark J. I.,

Journal:

Malaria Journal

Year:

2020

Language:

english

File:

PDF, 1.11 MB

english, 2020

20

Assessment of the therapeutic value of new medicines marketed in Australia

Wonder, Michael J

Journal:

Journal of Pharmaceutical Policy and Practice

Year:

2013

Language:

english

File:

PDF, 230 KB

english, 2013

21

Interpretation and Use of the Results of Proliferation Resistance Studies

Zentner, Michael D., Pomeroy, George, Bari, Robert A., Cojazzi, Giacomo G. M., Haas, Eckhart, Killeen, Thomas, Peterson, P., Whitlock, Jeremy J., Wonder, Edward F.

Journal:

Nuclear Technology

Year:

2012

Language:

english

File:

PDF, 249 KB

english, 2012

22

Are Australians Able to Access New Medicines on the Pharmaceutical Benefits Scheme in a More or Less Timely Manner? An Analysis of Pharmaceutical Benefits Advisory Committee Recommendations, 1999–2003

Michael J. Wonder, A. Munro Neville, Richard Parsons

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 79 KB

english, 2006

23

What can be gained from increased early-stage interaction between regulators, payers and the pharmaceutical industry?

Wonder, Michael

Journal:

Expert Review of Pharmacoeconomics & Outcomes Research

Year:

2014

Language:

english

File:

PDF, 527 KB

english, 2014

24

Registration and Reimbursement of New Cancer Medicines in Australia

Wonder, Michael

Journal:

Value in Health Regional Issues

Year:

2016

Language:

english

File:

PDF, 333 KB

english, 2016

25

Is there any evidence that the Trans Pacific Partnership Agreement will threaten access to affordable medicines and health equity in New Zealand?

Wonder, Michael, Milne, Richard

Journal:

Year:

2014

Language:

english

File:

PDF, 166 KB

english, 2014

26

Comparing Subsidized Access to Medicines Across Payer Systems

Michael Wonder,Richard Milne

Journal:

PharmacoEconomics

Year:

2013

Language:

english

File:

PDF, 157 KB

english, 2013

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски